Europese Unie -
Nederlands -
EMA (European Medicines Agency)
ngenla
pfizer europe ma eeig - somatrogon - growth and development - hypofyse en de hypothalamus hormonen en analogen - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
Italië -
Nederlands -
Ministero della Salute
spongostan polvere di gelatina emostatica riassorbibile
Europese Unie -
Nederlands -
EMA (European Medicines Agency)
sogroya
novo nordisk a/s - somapacitan - groei - hypofyse en hypothalamische hormonen en analogen - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).
Europese Unie -
Nederlands -
EMA (European Medicines Agency)
skytrofa (previously lonapegsomatropin ascendis pharma)
ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hypofyse en hypothalamische hormonen en analogen - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.